// App-Quantinova.ai

e24184 : Phase 0/1 of positron emission tomography (PET) imaging agent [18F]-ODS2004436 as a marker of EGFR mutation in patients with non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Alexandre Cochet

Principal Investigators

  • Nicolas Isambert

  • Pascal Foucher

  • Aurelie Bertaut

  • Cyril Berthet

  • Bruno P. Coudert

  • Jean-Bernard Deloye

  • Charles Coutant

  • Petra Blom

  • Gilles Viot

  • Jean-Marc Vrigneaud

  • Jan Hoflack

  • Yann Bouvet

  • Pierre Fumoleau

  • Philippe Genne

Medical Centers

  • Department of Nuclear Medicine, Centre G.F. Leclerc, Dijon, France

  • Service d'oncologie medicale CLCC Georges-Francois Leclerc, Dijon, France

  • Dijon University Hospital Center, Dijon, France

  • Georges-Francois Leclerc Cancer Center, Dijon, France

  • Oncodesign, Dijon, France

  • Department of Medical Oncology, Center GF Leclerc, Dijon, France

  • Biopole Clermont-Limagne Saint-Beauzire, Saint-Beauzire, France

  • Center Georges-Francois Leclerc, Dijon, France

  • Cyclopharma, Saint-Beauzire 63360, France

  • CYCLOPHARMA, Saint Beauzaire, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02847377

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved